CHM — Chimeric Therapeutics Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- AU$0.16m
- -AU$0.64m
Brief: Chimeric Therapeutics To Raise Up To A$3.2 Mln At A$0.005 Per Share
Brief: Chimeric Therapeutics Announces A$4.0 Million Non-Dilutionary Funding
Brief: Chimeric Therapeutics Seeks Trading Halt Pending Announcements In Relation To A Capital Raising, Non-Dilutionary Funding
Brief: Chimeric Therapeutics Says Appointment Of Rebecca Mcqualter As CEO
Brief: Chimeric Therapeutics Announces A$5 Million Placement
Australia's Chimeric Therapeutics gains as FY loss narrows
Brief: Chimeric Therapeutics Posts Net Loss For Year Attributable A$12.5 Mln
Brief: Chimeric Therapeutics Says Partnering With Cell Therapies Australia
Australia Chimeric Therapeutics rises on first enrolment in cancer cell therapy trial
Brief: Chimeric Therapeutics Says Jennifer Chow Gave Notice Of Resignation As CEO, Managing Director
Brief: Chimeric Therapeutics Announces FDA Clearance Of IND Application For CHM 2101
Chimeric Therapeutics soars on FDA nod for gastrointestinal cancer therapy
Brief: Chimeric Therapeutics Says Entitlement Offer To Raise A$10 Mln
Brief: Chimeric Therapeutics Seeks Trading Halt
Brief: Chimeric Therapeutics Says Execution Of Clinical Study Agreement With University Of Texas MD Anderson Cancer Center
Australia's Chimeric Therapeutics rises on agreement with MD Anderson
Brief: Chimeric Therapeutics Ltd Says Loss For The Year A$25.5 Mln
Brief: Chimeric Therapeutics Says Leslie Chong Resigned As Non-Executive Director
Brief: Chimeric Therapeutics Secures Up To A$12.6 Mln Through SPP